Department of Chemistry, College of science, University of AL-Qadisiyah, AL-Diwaniyah, Iraq.
Department of Medical Chemistry, College of Medicine, University of AL-Qadisiyah, Al-Diwaniyah, Iraq.
Arch Razi Inst. 2022 Aug 31;77(4):1481-1489. doi: 10.22092/ARI.2022.357618.2071. eCollection 2022 Aug.
Hyperthyroidism is a health problem characterized by an overactive thyroid gland, resulting in extra triiodothyronine (T3) and thyroxine (T4) production, as well as a decrease in thyroid-stimulating hormone (TSH). The oxidative stress indicators in hyperthyroid patients and the relationship with impaired metabolism of lipid are still controversial, especially in menopausal women suffering from a lack of ovulation hormones. In this study, blood samples were withdrawn from 120 subjects, including healthy premenopausal (n=30) and postmenopausal women (n=30) as control groups (G1 and G2), as well as 30 hyperthyroid women in each group of premenopausal and postmenopausal patient groups (G3 and G4). The levels of T3, T4, and TSH, blood pressure, and lipid profiles, such as triglyceride, total cholesterol (TC), high-density lipoprotein, and low-density lipoprotein, superoxide dismutase (SOD) activity, malondialdehyde (MDA), and advanced oxidation protein products (AOPP) in the two healthy control groups and patient groups with hyperthyroidism were measured. In addition, serum progesterone levels were measured by the Bio-Merieux kit France, according to the manufacturer's instructions. The results revealed a significant decrease in SOD activity in the postmenopausal group, as compared to that in premenopausal women and control groups. Hyperthyroidism groups demonstrated a significant increase in MDA and AOPP levels, compared to control groups. Patient groups reported a decreased level of progesterone, in comparison with control groups. Moreover, there was a significant increase in T3 and T4 in patient groups (G3 and G4), compared to that in control groups (G1 and G2). There was a significant increase in systolic and diastolic blood pressure in menopausal hyperthyroidism (G4), compared to that in other groups. The TC decreased significantly in G3 and G4, compared to that in both control groups (<0.05); nonetheless, there was no significant difference between patient groups (G3 and G4), as well as between control groups (G1 and G2). The study suggested that hyperthyroidism causes an increase in oxidative stress, which negatively affects the antioxidant system and drops levels of progesterone in both premenopausal and postmenopausal female patients. Therefore, low levels of progesterone are linked with hyperthyroidism, leading to aggravating symptoms of the disease.
甲状腺功能亢进症是一种由甲状腺过度活跃引起的健康问题,导致三碘甲状腺原氨酸(T3)和甲状腺素(T4)的产生增加,以及促甲状腺激素(TSH)的减少。甲状腺功能亢进症患者的氧化应激指标以及与脂质代谢受损的关系仍存在争议,尤其是在患有排卵激素缺乏的绝经后妇女中。在这项研究中,从 120 名受试者中抽取血液样本,包括健康的绝经前(n=30)和绝经后妇女(n=30)作为对照组(G1 和 G2),以及每组 30 名患有甲状腺功能亢进的绝经前和绝经后患者组(G3 和 G4)。测量了两组健康对照组和甲状腺功能亢进症患者组的 T3、T4 和 TSH 水平、血压以及血脂谱,如甘油三酯、总胆固醇(TC)、高密度脂蛋白和低密度脂蛋白、超氧化物歧化酶(SOD)活性、丙二醛(MDA)和高级氧化蛋白产物(AOPP)。此外,根据制造商的说明,使用法国生物梅里埃试剂盒测量血清孕激素水平。结果显示,与绝经前妇女和对照组相比,绝经后组的 SOD 活性显著降低。与对照组相比,甲状腺功能亢进症组的 MDA 和 AOPP 水平显著升高。与对照组相比,患者组的孕激素水平降低。此外,与对照组(G1 和 G2)相比,患者组(G3 和 G4)的 T3 和 T4 水平显著升高。与其他组相比,绝经后甲状腺功能亢进症患者的收缩压和舒张压显著升高(G4)。与两组对照组相比,G3 和 G4 的 TC 显著降低(<0.05);然而,患者组(G3 和 G4)之间以及对照组(G1 和 G2)之间没有显著差异。该研究表明,甲状腺功能亢进症会导致氧化应激增加,从而对抗氧化系统产生负面影响,并降低绝经前和绝经后女性患者的孕激素水平。因此,孕激素水平低与甲状腺功能亢进症有关,导致疾病症状加重。